Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
V. Polotsky (Baltimore, MD, USA). CPAP treatment: effects on plasma lipids and liver function. Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options

Member's Comments

No comment yet.

Related content which might interest you: Effects of OSA on metabolic dysfunction in children Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Genetic factors: OSAS, obesity or both? Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Data from animal models: role of IH and obesity Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Inflammation in obese adipose tissue Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Introduction and epidemiology of dyslipidemia in OSAS patients Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Does sleep loss play a role in adipose tissue dysfunction? Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Visceral adipose tissue as a target for therapeutic intervention: an update Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Effects of OSA on metabolic dysfunction in adolescents - is OSA relevant for adolescent obesity? Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Metabolic consequences in obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006 Influence of body mass index on asthma severity and control: A cross-sectional study Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Interaction between body weight obstructive sleep apnea (OSA) on C-reactive protein (CRP) in an otherwise healthy population: The EPIOSA study Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015 Reductions in body weight and sleep apnea severity in morbidly obese subjects – Which factors contribute to improvements in lung function and blood gases? Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015 Obstructive sleep apnea syndrome in obese patients: adiponectin levels Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Anthropometric markers of adiposity and visceral adiposity index (VAI) in patients with OSA Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013 Is desaturation Index, a better predictor of metabolic syndrome than apnoea-hypopnoea index? Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea Year: 2016 Does the effect of posture and fat distribution on airways resistance contribute to the development of obesity hypoventilation syndrome? Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders Year: 2016 Risk for asthma is associated with higher BMI, but not with obesity? Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015